Inventor
MADUSKUIE JR THOMAS P
US34 patents
⚠️ This page may combine multiple inventors who share the name “MADUSKUIE JR THOMAS P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INCYTE CORP
23 patentsUS9624241B2Apr 18, 2017
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP27 citations98
US9540368B2Jan 10, 2017
1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
INCYTE CORP35 citations98
US11059821B2Jul 13, 2021
1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
INCYTE CORP13 citations94
US10781209B2Sep 22, 2020
1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
INCYTE CORP12 citations94
US10472358B2Nov 12, 2019
1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
INCYTE CORP19 citations94
US10464947B2Nov 5, 2019
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP17 citations94
US10092570B2Oct 9, 2018
Heterocyclylamines as PI3K inhibitors
INCYTE CORP17 citations94
US9957268B2May 1, 2018
1H-pyrrolo[2,3,c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
INCYTE CORP23 citations94
US9938294B2Apr 10, 2018
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP24 citations94
US9730939B2Aug 15, 2017
Heterocyclylamines as PI3K inhibitors
INCYTE CORP23 citations94
US9533997B2Jan 3, 2017
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP29 citations94
US9309251B2Apr 12, 2016
Bicyclic azaheterocyclobenzylamines as PI3K inhibitors
INCYTE CORP25 citations94
US9290514B2Mar 22, 2016
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP33 citations94
US10646492B2May 12, 2020
Heterocyclylamines as PI3K inhibitors
INCYTE CORP9 citations93
US9944646B2Apr 17, 2018
Bicyclic azaheterocyclobenzylamines as PI3K inhibitors
INCYTE CORP16 citations93
US9815839B2Nov 14, 2017
N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
INCYTE CORP20 citations93
US11702416B2Jul 18, 2023
1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
INCYTE CORP4 citations86
US10919912B2Feb 16, 2021
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP10 citations86
US11498926B2Nov 15, 2022
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP4 citations84
US11433071B2Sep 6, 2022
Heterocyclylamines as PI3K inhibitors
INCYTE CORP3 citations84
US10259818B2Apr 16, 2019
Bicyclic azaheterocyclobenzylamines as PI3K inhibitors
INCYTE CORP12 citations84
US12201636B2Jan 21, 2025
Heterocyclylamines as PI3K inhibitors
INCYTE CORP0 citations63
US12227502B2Feb 18, 2025
1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c] pyridin-7(6H)-ones as inhibitors of BET proteins
INCYTE CORP0 citations62
BRISTOL MYERS SQUIBB PHARMA CO
4 patentsUS6403632B1Jun 11, 2002
Lactam metalloprotease inhibitors
BRISTOL MYERS SQUIBB PHARMA CO78 citations95
US6495565B2Dec 17, 2002
β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α
BRISTOL MYERS SQUIBB PHARMA CO50 citations91
US6984648B2Jan 10, 2006
Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α
BRISTOL MYERS SQUIBB PHARMA CO15 citations82
US6743807B2Jun 1, 2004
Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α
BRISTOL MYERS SQUIBB PHARMA CO15 citations82
DU PONT MERCK PHARMA
3 patentsUS5166214ANov 24, 1992
Use of imidazoles for the treatment of atherosclerosis
DU PONT MERCK PHARMA41 citations91
US5179117AJan 12, 1993
Antihypercholesterolemic 2-substituted imidazoles
DU PONT MERCK PHARMA20 citations74
US5318984AJun 7, 1994
Imidazoles for the treatment of atherosclerosis
DU PONT MERCK PHARMA15 citations72